U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 133

1.
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration
Kristy P Robledo, Shilo Lefresne, Yu Yang Soon, Arjun Sahgal, Mark B Pinkham, Alan Nichol, Ross Andrew Soo, Ambika Parmar, Fiona Hegi-Johnson, Mark Doherty, Benjamin J Solomon, David B Shultz, Ivan WK Tham, Adrian G Sacher, Jeremy Tey, Cheng Nang Leong, Wee Yao Koh, Yiqing Huang, Yvonne Li En Ang, Jiali Low, Clement Yong, Mei Chin Lim, Ai Peng Tan, Chee Khoon Lee, Cheryl Ho
BMJ Open. 2024; 14(7): e078335. Published online 2024 Jul 5. doi: 10.1136/bmjopen-2023-078335
PMCID:
PMC11227758
AbstractArticlePDF–335K
2.
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer
Seema Nagpal, Michael T Milano, Veronica L Chiang, Scott G Soltys, Alexandria Brackett, Lia M Halasz, Amit K Garg, Arjun Sahgal, Manmeet S Ahluwalia, Martin C Tom, Joshua D Palmer, Jonathan P S Knisley, Samuel T Chao, Melanie Hayden Gephart, Tony J C Wang, Simon S Lo, Eric L Chang
Neuro Oncol. 2024 Jul; 26(7): 1195–1212. Published online 2024 Mar 9. doi: 10.1093/neuonc/noae041
PMCID:
PMC11226873
AbstractArticlePDF–290K
3.
Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs
Lige Wu, Zihua Zou, Yan Li, Xuezhi Hao, Jianming Ying, Junling Li, Puyuan Xing
J Transl Med. 2024; 22: 585. Published online 2024 Jun 20. doi: 10.1186/s12967-024-05388-0
PMCID:
PMC11191366
AbstractArticlePDF–2.2M
4.
脑脊液循环肿瘤DNA在非小细胞肺癌柔脑膜转移中的临床应用进展
LI Yubin, LI Xiaoyan
Zhongguo Fei Ai Za Zhi. 2024 May 20; 27(5): 376–382. Chinese. doi: 10.3779/j.issn.1009-3419.2024.102.16
PMCID:
PMC11183312
AbstractArticlePDF–1.1M
5.
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
Gee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, Heng-Sheng Chao, Cheng-Ta Yang, Chien-Chung Lin, Jen-Yu Hung, Sheng-Yen Hsiao, Chin-Chou Wang, Chih-Feng Chian, Te-Chun Hsia, Yuh-Min Chen
PLoS One. 2024; 19(5): e0303046. Published online 2024 May 16. doi: 10.1371/journal.pone.0303046
PMCID:
PMC11098304
AbstractArticlePDF–986K
6.
Targeted therapeutic options in early and metastatic NSCLC-overview
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
Pathol Oncol Res. 2024; 30: 1611715. Published online 2024 Mar 28. doi: 10.3389/pore.2024.1611715
PMCID:
PMC11006988
AbstractArticlePDF–2.6M
7.
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial
S. Michels, B. Massutí, I. Vasyliv, J. Stratmann, J. Frank, A. Adams, E. Felip, C. Grohé, D. Rodriguez-Abreu, H. Bischoff, E. Carcereny i Costa, J. Corral, E. Pereira, J. Fassunke, R.N. Fischer, A. Insa, S. Koleczko, L. Nogova, M. Reck, T. Reutter, R. Riedel, D. Schaufler, M. Scheffler, M. Weisthoff, M. Provencio, S. Merkelbach-Bruse, M. Hellmich, M. Sebastian, R. Büttner, T. Persigehl, R. Rosell, J. Wolf
ESMO Open. 2024 Feb; 9(2): 102237. Published online 2024 Feb 12. doi: 10.1016/j.esmoop.2024.102237
PMCID:
PMC10937203
AbstractArticlePDF–518K
8.
High efficacy of brigatinib for brain metastases in ALK fusion gene‐positive non‐small cell lung cancer: A case series
Kei Morikawa, Yu Numata, Yusuke Shinozaki, Shotaro Kaneko, Aya Matsushima, Makoto Nishida, Hirotaka Kida, Hiroshi Handa, Hiroki Nishine, Masamichi Mineshita
Thorac Cancer. 2024 Feb; 15(6): 496–499. Published online 2023 Dec 30. doi: 10.1111/1759-7714.15207
PMCID:
PMC10883856
AbstractArticlePDF–792K
9.
Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
Pang-Shuo Perng, Heng-Juei Hsu, Jung-Shun Lee, Liang-Chao Wang, Chih-Yuan Huang, Chih-Hao Tien, Yu-Hsuan Lai, Po-Lan Su, Hao-Hsiang Hsu, Liang-Yi Chen, Po-Hsuan Lee
World J Surg Oncol. 2023; 21: 368. Published online 2023 Nov 25. doi: 10.1186/s12957-023-03248-7
PMCID:
PMC10675964
AbstractArticlePDF–3.5M
10.
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases
Marcelo V. Negrao, Alexander I. Spira, Rebecca S. Heist, Pasi A. Jänne, Jose M. Pacheco, Jared Weiss, Shirish M. Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G. Christensen, Joshua K. Sabari
J Clin Oncol. 2023 Oct 1; 41(28): 4472–4477. Published online 2023 Jun 16. doi: 10.1200/JCO.23.00046
PMCID:
PMC10553074
AbstractArticlePDF–597K
11.
Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer
Narine E. Wandrey, Dexiang Gao, Tyler P. Robin, Joseph N. Contessa, Charu Singh, Veronica Chiang, Jing Li, Aileen Chen, Yan Wang, Jason P. Sheehan, Sunil W. Dutta, Stephanie E. Weiss, Jonathan Paly, Chad G. Rusthoven
Lung Cancer. Author manuscript; available in PMC 2023 Oct 5.
Published in final edited form as: Lung Cancer. 2023 Feb; 176: 144–148. Published online 2022 Dec 12. doi: 10.1016/j.lungcan.2022.11.019
PMCID:
PMC10552603
AbstractArticlePDF–527K
12.
Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report
Auro del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonseca
J Med Case Rep. 2023; 17: 407. Published online 2023 Sep 25. doi: 10.1186/s13256-023-04139-x
PMCID:
PMC10519093
AbstractArticlePDF–1.1M
13.
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
Qing Zhou, He-Long Zhang, Li-Yan Jiang, Yuan-Kai Shi, Yuan Chen, Jin-Ming Yu, Cai-Cun Zhou, Yong He, Yan-Ping Hu, Zong-An Liang, Yue-Yin Pan, Wen-Lei Zhuo, Yong Song, Gang Wu, Gong-Yan Chen, You Lu, Cui-Ying Zhang, Yi-Ping Zhang, Ying Cheng, Shun Lu, Chang-Li Wang, Jian-Ying Zhou, Yun-Peng Liu, Jian-Xing He, Jie Wang, Yi-Long Wu
J Cancer Res Clin Oncol. 2023; 149(12): 10771–10780. Published online 2023 Jun 14. doi: 10.1007/s00432-023-04923-8
PMCID:
PMC10423102
AbstractArticlePDF–1.7M
14.
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer
Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, Sophia Auduong, Seyda Kilic, David Deng, Nobuhiko Kanaya, David Kozono, Jing Zhou, Jeffrey J Gray, Esther Revai-Lechtich, Yanni Zhu, Khalid Shah
Stem Cells Transl Med. 2023 Jul; 12(7): 444–458. Published online 2023 Jun 13. doi: 10.1093/stcltm/szad033
Expression of Concern in:
Stem Cells Transl Med. 2024 Feb 5
PMCID:
PMC10346421
AbstractArticlePDF–46M
15.
Repotrectinib exhibits potent anti-tumor activity in treatment-naive and solvent-front-mutant ROS1-rearranged non-small cell lung cancer
Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, Hyeong-Seok Joo, You Won Lee, Hun Mi Choi, Chae Won Park, Seong Gu Heo, Han Na Kang, Sung Sook Lee, Adam J. Schoenfeld, Alexander Drilon, Seok Gu Kang, Hyo Sup Shim, Min Hee Hong, J. Jean Cui, Hye Ryun Kim, Byoung Chul Cho
Clin Cancer Res. Author manuscript; available in PMC 2023 Jun 21.
Published in final edited form as: Clin Cancer Res. 2020 Jul 1; 26(13): 3287–3295. Published online 2020 Apr 8. doi: 10.1158/1078-0432.CCR-19-2777
PMCID:
PMC10283448
AbstractArticlePDF–1.7M
16.
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer
Hye Sook Kim, Kun Young Lim, Soo‐Hyun Lee, Hyae Young Kim, Youngjoo Lee, Ji‐Youn Han
Cancer Med. 2023 Jun; 12(11): 12285–12298. Published online 2023 Apr 25. doi: 10.1002/cam4.5926
PMCID:
PMC10278531
AbstractArticlePDF–3.3M
17.
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
Silvia Novello, Raffaele Califano, Niels Reinmuth, Antonella Tamma, Tarun Puri
Oncologist. 2023 May; 28(5): 402–413. Published online 2023 Feb 23. doi: 10.1093/oncolo/oyac264
PMCID:
PMC10166168
AbstractArticlePDF–1.0M
18.
Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
Shiva Najjary, Johan M. Kros, Willem de Koning, Disha Vadgama, Karishma Lila, Janina Wolf, Dana A. M. Mustafa
Acta Neuropathol Commun. 2023; 11: 64. Published online 2023 Apr 15. doi: 10.1186/s40478-023-01542-9
PMCID:
PMC10105417
AbstractArticlePDF–6.3M
19.
Haplotype-GGGT in long non-coding RNA MALAT1 inhibits brain metastatic lung cancer and lymph nodes of lung cancer via the MALAT1/miR-328/KATNB1
Tingting Liu, Jianpeng Ma, Dongmei Hou, Weiqi Wang, Hetao Cao
Aging (Albany NY) 2023 Mar 31; 15(6): 1918–1930. Published online 2023 Mar 2. doi: 10.18632/aging.204563
PMCID:
PMC10085600
AbstractArticlePDF–1.2M
20.
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review
Valerio Nardone, Caterina Romeo, Emma D’Ippolito, Pierpaolo Pastina, Maria D’Apolito, Luigi Pirtoli, Michele Caraglia, Luciano Mutti, Giovanna Bianco, Antonella Consuelo Falzea, Rocco Giannicola, Antonio Giordano, Pierosandro Tagliaferri, Claudia Vinciguerra, Isacco Desideri, Mauro Loi, Alfonso Reginelli, Salvatore Cappabianca, Pierfrancesco Tassone, Pierpaolo Correale
Radiol Med. 2023; 128(3): 316–329. Published online 2023 Feb 14. doi: 10.1007/s11547-023-01602-z
PMCID:
PMC10020247
AbstractArticlePDF–932K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center